Table 1.

Combinations of different mouse backgrounds and parasite strains combinations allow the study of many disease profiles.

Mouse strain	Infection	Infection/pathology/protection	Ref.
C57BL/6 C57BL/6J C57BL/6N C57BL/6AnNCr 129/Ola x C57BL/6 129P2Sv/Ev 129 Sv/Ev x C57BL/6	P. berghei ANKA	ECM	[61–76]
	P. berghei ANKA-luc (231c11)		[21, 77]
	P. berghei ANKA-GFP		[78, 79]
	P. berghei ANKA clone 15cy1		[80, 81]
	P. berghei ANKA-GFP clone 15cy1		[82]
	P. berghei ANKA clone BdS		[26, 83]
	P. berghei ANKA sporozoite		[73]
	P. berghei ANKA clone 15cy1 sporozoite		[80, 84]
C57BL/6	P. berghei K173	Protection from ECM	[67]
	P. yoelii nigeriensis N67C	Lethal hyperparasitemia and severe anemia	[85]
	P. yoelii 17XNL	Protection from lethal hyperparasitemia and severe anemia	[86]
	P. yoelii yoelii 265 BY uncloned line		[87]
	P. yoelii nigeriensis N67		[85]
	P. berghei NK65	Liver injury	[88]
		Malaria-associated acute respiratory distress syndrome	[76]
	P. berghei NK65-GFP	Placental malaria	[89]
	P. chabaudi chabaudi AS	Protection in uncomplicated malaria	[77, 90]
	P. chabaudi AS		[76, 91]
	P. berghei ANKA-luc sporozoite	Liver-stage malaria	[92]
	P. berghei NK65 sporozoite
	P. yoelii 17XNL sporozoite
C57BL/6.C-H2 d/bBy	P. berghei ANKA-GFP sporozoite	Liver-stage malaria	[93]
CBA/J	P. berghei ANKA	ECM	[75]
	P. yoelii 17X	Protection from lethal hyperparasitemia and severe anemia	[94]
	P. yoelii 17XNL
CBA/T6	P. berghei ANKA	ECM	[95]
	P. berghei K173	Protection from ECM
CBA/CaH	P. chabaudi adami 556 KA	Protection against blood-stage malaria	[96]
DBA/2	P. berghei ANKA	Protection from ECM	[84]
		Acute lung injury
129 Sv/Ev	P. berghei ANKA clone 1.4	ECM	[97]
	P. chabaudi chabaudi AS	Protection against blood-stage malaria	[98]
BALB/c	P. berghei ANKA	Protection from ECM	[65, 70, 74, 75, 84]
	P. berghei ANKA clone BdS		[26]
	P. berghei ANKA-GFP		[79]
BALB/cByJ SW	P. yoelii 17XL	Lethal hyperparasitemia and severe anemia	[94]
	P. yoelii 17XNL	Protection from lethal hyperparasitemia and severe anemia